ARCHIBUGI, LIVIA
 Distribuzione geografica
Continente #
NA - Nord America 277
AS - Asia 224
EU - Europa 223
SA - Sud America 3
Totale 727
Nazione #
US - Stati Uniti d'America 276
CN - Cina 130
SG - Singapore 86
SE - Svezia 82
IT - Italia 80
RU - Federazione Russa 31
FI - Finlandia 8
DE - Germania 6
FR - Francia 6
NL - Olanda 4
TR - Turchia 4
BR - Brasile 3
GB - Regno Unito 3
IN - India 2
PL - Polonia 2
CA - Canada 1
IE - Irlanda 1
KR - Corea 1
SA - Arabia Saudita 1
Totale 727
Città #
Singapore 66
Ashburn 62
Shanghai 54
Milan 48
New York 32
Boardman 29
Washington 17
Lawrence 16
Princeton 16
Moscow 15
Dallas 9
Guangzhou 7
Beijing 6
Rome 6
Seattle 6
Shenzhen 6
Carlsbad 5
Helsinki 5
Jiaxing 4
Mountain View 4
Amsterdam 3
Florence 3
Lappeenranta 3
London 3
Los Angeles 3
Munich 3
Wuxi 3
Bologna 2
Cagliari 2
Huzhou 2
Kolkata 2
Nantong 2
Paris 2
Pisa 2
Rimini 2
Rio de Janeiro 2
Romainville 2
Teramo 2
Verona 2
Wenzhou 2
Xi'an 2
Zhengzhou 2
Arezzo 1
Cassano d'Adda 1
Dublin 1
Foshan 1
Germantown 1
Kassel 1
Missaglia 1
Nanjing 1
Prineville 1
Reggio Emilia 1
Riyadh 1
Santa Clara 1
Taizhou 1
Toronto 1
Wuhan 1
Totale 479
Nome #
ENDOSCOPY-BASED INVESTIGATION OF NOVEL BIOMARKERS FOR PANCREATIC CANCER 60
Necrosis volume and Choi criteria predict the response to endoscopic ultrasonography-guided HybridTherm ablation of locally advanced pancreatic cancer 33
Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction 26
Diagnosis and treatment in chronic pancreatitis: an international survey and case vignette study 26
High sensitivity of ROSE-supported ERCP-guided brushing for biliary strictures 26
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer 25
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma 24
Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk 24
Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk 24
Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women. 23
Chronic use of statins and acetylsalicylic acid and incidence of post-endoscopic retrograde cholangiopancreatography acute pancreatitis: A multicenter, prospective, cohort study 23
RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of Molecular Features 23
Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma 23
Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility 22
Genetic Polymorphisms Involved in Mitochondrial Metabolism and Pancreatic Cancer Risk 21
EUS-Guided Anti-tumor Therapy: Ablation of Solid Neoplasms 20
Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy 20
Polymorphic variants involved in methylation regulation: a strategy to discover risk loci for pancreatic ductal adenocarcinoma 19
Infection Control Practices and Outcomes of Endoscopy Units in the Lombardy Region of Italy: A Survey From the Italian Society of Digestive Endoscopy During COVID-19 Spread 19
Genetic and non-genetic risk factors for early-onset pancreatic cancer 17
Risk factors for the occurrence of ampullary tumors: A case-control study 17
Genome-wide association study identifies an early onset pancreatic cancer risk locus 17
Communication, understanding and engagement of patients with pancreatic cancer at time of diagnosis 16
Slow-pull compared to suction technique for EUS-guided sampling of pancreatic solid lesions: a meta-analysis of randomized controlled trials 16
Statin use improves survival in patients with pancreatic ductal adenocarcinoma: A meta-analysis 16
Exocrine pancreatic insufficiency in diabetic patients. prevalence, mechanisms, and treatment 14
Present and Future of Local Therapies for Unresectable Pancreatic Cancer 14
The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years’ experience of association studies to understand the genetic architecture of pancreatic cancer 14
Machine learning for the prediction of post-ERCP Pancreatitis risk: A proof-of-concept study 14
EUS-Guided Choledocho-duodenostomy Using Lumen Apposing Stent Versus ERCP With Covered Metallic Stents in Patients With Unresectable Malignant Distal Biliary Obstruction: A Multicenter Randomized Controlled Trial (DRA-MBO Trial) 13
Chronic use of statins and aminosalicylic acid and incidence of post-ERCP acute pancreatitis. Preliminary data from the STARK study, a prospective international, multicenter, cohort study 13
EUS diagnostic puncture 12
The Italian registry of families at risk for pancreatic cancer (IRFARPC): implementation and evolution of a national program for pancreatic cancer surveillance in high-risk individuals 12
Alcohol and gastrointestinal cancers 11
Systematic review and meta-analysis. small intestinal bacterial overgrowth in chronic pancreatitis 11
EUS-guided gastroenterostomy in a COVID-19-infected patient with duodenal stenosing lymphoma (with videos) 10
Outcomes of a 3-Year Prospective Surveillance in Individuals at High Risk of Pancreatic Cancer 10
Needle-Tract Seeding of Pancreatic Cancer after EUS-FNA: A Systematic Review of Case Reports and Discussion of Management 10
How to do EUS - guided Ablation of Pancreatic Neurendocrine Tumors 9
Role of endoscopic ultrasound in the age of personalized medicine 9
Standardization of a Radiofrequency Ablation Tool in an Ex-Vivo Porcine Liver Model 9
Gynecological and reproductive factors and the risk of pancreatic cancer. a case-control study 9
Early onset pancreatic cancer. Risk factors, presentation and outcome 9
A scan of all coding region variants of the human genome, identifies 13q12.2-rs9579139 and 15q24.1-rs2277598 as novel risk loci for pancreatic ductal adenocarcinoma 9
Exclusive and Combined Use of Statins and Aspirin and the Risk of Pancreatic Cancer: a Case-Control Study 9
The baseline nutritional status assessed by MUST score has a low accuracy in predicting the risk of hospitalization during follow-up in patients with chronic pancreatitis: A cohort study: CP nutritional status and complications 8
Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk 8
Surveillance of Individuals at High Risk of Developing Pancreatic Cancer: A Prevalence Meta-analysis to Estimate the Rate of Low-yield Surgery 6
Association of Smoking with progression from low-risk to high-risk intraductal papillary mucinous neoplasms and pancreatic cancer 5
P.04.4 PRESENTATION SYMPTOMS AND RISK FACTORS ARE ASSOCIATED WITH DIAGNOSTIC DELAY AND DISEASE STAGE BUT NOT WITH SURVIVAL OF PATIENTS WITH PANCREATIC CANCER 5
P.04.12 ROLE OF CYST FEATURES AND PATIENTS' FACTORS IN PREDICTING THE RISK OF PROGRESSION IN BD-IPMN UNDERGOING FOLLOW-UP 3
Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients 1
Totale 837
Categoria #
all - tutte 9.349
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.349


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 0 10 4 3 0 0 0 0 0
2021/202250 0 0 0 6 8 0 1 1 7 27 0 0
2022/2023148 35 30 14 4 5 19 6 18 3 0 11 3
2023/2024385 34 19 42 34 39 69 18 37 5 6 24 58
2024/2025237 78 29 34 41 55 0 0 0 0 0 0 0
Totale 837